Envista Holdings Corporation (NVST)
NYSE: NVSTHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NVST stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.67B
- P/E (TTM)
- 5.95
- Forward P/E
- 13.68
- EPS (TTM)
- $3.85
- Dividend yield
- None
- 52-week range
- 19.67 – 30.42
- Day range
- 22.77 – 23.76
- Volume / Avg
- 2.31M / 2.87M
- Beta
- —
- Shares outstanding
- 160.34M
52-week range
NVST stock today
Envista (NVST) closed at $22.91 on Nov 20, down 1.55% (-$0.36), versus the S&P 500's 3.70% decline. Shares are 24.7% below their 52-week high of $30.42, set on Feb 11, 2026 and 16.5% above the 52-week low of $19.67, in the middle of the past year's range. NVST is up 5.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 15.2%.
At 6.0x trailing earnings, Envista trades below the peer-group median of 69.7x. Its forward P/E of 13.7x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Envista
Company profileEnvista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Paul A. Keel
- Headquarters
- Brea, CA
- Employees
- 12,000
- IPO year
- 2019
- Website
- envistaco.com
Financial highlights
Full financialsIn fiscal 2025, Envista generated $2.72 billion in revenue, up 8.3% from fiscal 2024. Net income was $47.0 million, for a net margin of 1.7% versus a median of 1.7% in the prior 5 years. Gross margin was 54.7% (flat year over year) and operating margin 7.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $2.72B | $2.51B | $2.57B | $2.57B | $2.51B |
| Growth | +8.32% | -2.18% | -0.10% | +2.40% | +30.06% |
| Net income | $47.00M | $-1.12B | $-100.20M | $243.10M | $340.50M |
| EPS (diluted) | $0.28 | $-6.50 | $-0.60 | $1.37 | $1.92 |
Analyst forecast
ForecastConsensus (15 analysts)
buy
Avg. price target
$28.92+26.23%
- Strong buy 2
- Buy 5
- Hold 8
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 4, 2026
- EPS actual vs est.
- $3.11 vs $0.35
- Surprise
- +788.57%
NVST news
All NVST news- Here's Why You Should Retain NVST Stock in Your Portfolio for NowNasdaqNVST, IDXX, GMED, PAHC
- Envista Announces Pricing of $430 Million of Senior NotesPR Newswire
- Envista (NVST) Q3 2026 Earnings Call TranscriptNasdaqNVST, UHAL.B
- What Envista (NVST) Said on Its Q3 Earnings CallNasdaq
- Envista Reports Third Quarter 2026 ResultsPR Newswire
- Envista Q3 Earnings Ahead: Product Innovation to Drive GrowthNasdaqNVST, ACHC, TGTX, RVTY
- Envista Holdings Corporation Announces Publication of 2025 Sustainability ReportNasdaq
- Envista Announces Release of 2025 Sustainability ReportPR Newswire
Envista peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HTFLHeartflow Inc. | 46.69 | +4.62% | $4.10B | vs NVST |
| PLSEPulse Biosciences Inc | 45.55 | +2.57% | $3.35B | vs NVST |
| STVNStevanato Group S.p.A. | 15.65 | -1.76% | $4.27B | vs NVST |
| IRTCiRhythm Holdings Inc. | 94.72 | +0.51% | $3.18B | vs NVST |
| ICUIICU Medical Inc. | 172.52 | -1.84% | $4.31B | vs NVST |
| MMEDMiniMed Group Inc. | 16.01 | -1.54% | $4.50B | vs NVST |
| ATRCAtriCure Inc. | 55.39 | +2.37% | $2.82B | vs NVST |
| MMSIMerit Medical Systems Inc. | 84.34 | -0.08% | $5.05B | vs NVST |
Indexes, lists and sector
Envista stock FAQ
What is Envista's stock price today?
NVST last traded at $22.91 as of Nov 20, 4:00 PM EST, down 1.55% on the day. Prices are delayed at least 15 minutes.
What is NVST's P/E ratio?
NVST trades at a trailing P/E ratio of 5.95 and a forward P/E of 13.68, compared with a median of 69.7 for its closest peers.
Who is Envista's CEO?
Mr. Paul A. Keel is the chief executive officer of Envista Holdings Corporation, which has about 12,000 employees.
What is the NVST 52-week high?
The 52-week high for NVST is $30.42 and the 52-week low is $19.67. The stock is currently 24.7% below its high.